fda warning letter compounding semaglutide news Beyond the Headlines: Letters to GLP-1 Compounders FDA warns dangers of using

npj Cardiovasc Health

Methylenetetrahydrofolate reductase (MTHFR) polymorphism is associated with an increased risk of gynecological cancers

Larsen also noted that Marty Makary, M.D., President Donald Trump's pick to lead the FDA, will have "influence over the enforcement of semaglutide compounding and personalization efforts." Makary is an executive at Sesame, another telehealth company that connects consumers with physicians to prescribe compounded weight loss drugs

If youve been exploring medical weight loss options, youve probably noticed a surge in people searching for semaglutide injections near me

"Many times obesity treatment is framed as a limited duration intervention that once people get to a weight goal or percentage of weight reduction, that then treatment can be discontinued," Almandoz says